Article
Aberrant TNF signaling in pancreatic lymph nodes of patients with Type 1 Diabetes
2024-06-03
Abstract excerpt
The therapeutic landscape for Type 1 Diabetes (T1D) is rapidly changing as ongoing clinical trials aim to delay beta-cell loss by inhibiting proinflammatory cytokines. However, the precise timing and cellular contexts of cytokine dysregulation remains unknown. We generated the largest existing measurement of gene expression and chromatin accessibility in ∼1 million immune cells from the pancreatic lymph nodes and...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3c65a0af-02ae-57b1-93c4-974be6b4ee2c
- DOI
- 10.1101/2024.05.31.596885
